Daily News Archive
Daily News Subscription
US Vets Say Drug Summit "Springboard To Action"
Dr. Scott Palmer, racing committee chairman for the American Association Of Equine Practitioners, told the medication conference: “The summit represents a new beginning & a new opportunity to begin a journey. I sensed a spirit of consensus that our problems are real & medication is one of them. We have the opportunity to use this summit as a springboard to develop actions to address these issues.” The AAEP organised the summit in cooperation with the US National Thoroughbred Racing Association & the US Racing Medication And Testing Consortium “to educate industry leaders here & abroad about the use of the anti-bleeder medication furosemide (known by the brand name Salix) in the US”, which is “the only racing jurisdiction in the world that allows its race-day use”. The next step will be a “follow-up meeting in July of the RMTC board, which will take over the lead in the debate & analysis of race-day medication use because it is a consortium of 25 racing industry stakeholders”. The RMTC’s mission “is to develop & promote uniform medication rules, policies & testing standards”. To read the full report, click on the 2nd top link in The Great Debate panel on the right-hand-side of this page.